These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results. Poon RT; Fan ST JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014 [TBL] [Abstract][Full Text] [Related]
47. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632 [TBL] [Abstract][Full Text] [Related]
49. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials. Yu G; Li S; Wan R; Wang X; Hu G Pancreas; 2015 May; 44(4):561-9. PubMed ID: 25822153 [TBL] [Abstract][Full Text] [Related]
50. Somatostatin for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a never-ending story? Chen CC J Chin Med Assoc; 2009 Feb; 72(2):57-9. PubMed ID: 19251531 [No Abstract] [Full Text] [Related]
51. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Lee KT; Lee DH; Yoo BM Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260 [TBL] [Abstract][Full Text] [Related]
52. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Bai Y; Gao J; Shi X; Zou D; Li Z Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955 [TBL] [Abstract][Full Text] [Related]
53. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial. Yoo KS; Huh KR; Kim YJ; Kim KO; Park CH; Hahn T; Park SH; Kim JH; Park CK; Kwon YJ; Lehman GA Pancreas; 2011 Mar; 40(2):181-6. PubMed ID: 21206331 [TBL] [Abstract][Full Text] [Related]
54. Does wire-guided cannulation prevent post-ERCP pancreatitis?: a meta-analysis. Madhoun MF; Maple JT Am J Gastroenterol; 2010 Apr; 105(4):960. PubMed ID: 20372145 [No Abstract] [Full Text] [Related]
55. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis. Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176 [TBL] [Abstract][Full Text] [Related]
56. Risk of post-endoscopic retrograde cholangiopancreatography pancreatitis and ways to prevent it: old myths, a current need? The case of allopurinol. Andriulli A; Annese V Clin Gastroenterol Hepatol; 2008 Apr; 6(4):374-6. PubMed ID: 18387495 [No Abstract] [Full Text] [Related]
57. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Lyu Y; Cheng Y; Wang B; Xu Y; Du W BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142 [TBL] [Abstract][Full Text] [Related]
58. [Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, non-randomized study]. Vila JJ; Jiménez FJ; Prieto C; Borobio E; Juanmartiñena JF; Borda F Gastroenterol Hepatol; 2006 Apr; 29(4):231-6. PubMed ID: 16584693 [TBL] [Abstract][Full Text] [Related]
59. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Moretó M; Zaballa M Br J Surg; 2002 May; 89(5):628; author reply 629. PubMed ID: 12019509 [No Abstract] [Full Text] [Related]
60. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]